Delivery Order SPE2DB20D1109-SPE2DB25FP42A
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $5.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,561.65 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,265.90 delivery order on July 18, 2025, for HUMIRA (CF) Pen 40 mg/0.4 mls, with completion scheduled for July 21, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,907.90 to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) Pen 40 mg/0.4 mL, a TNF-inhibitor biologic used to treat autoimmune conditions. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The contract was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, and performance will occur at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $8,685.95 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory diseases. This non-set-aside, firm fixed-price contract was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine procurement action under the...
- The Defense Logistics Agency awarded a delivery order valued at $12,864.94 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. The contract was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Humira Pen 40mg/0.4ml medication. The $12,903.69 contract has a completion date of January 29, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this delivery order....
- This is a $22,165.92 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS medication. The contract has an ultimate completion date of July 30, 2024 and is not set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $4,609.08 to AmerisourceBergen Drug Corp for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract has a firm fixed price and an ultimate completion date of August 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor on this contract, which is not designated as a set-aside. This award is likely part of a larger Indefinite Delivery Contract (IDC) that...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,489.14 contract is for the delivery of HUMIRA(CF) PEN CRHN-UC-HS 80MGS to a location in Conshohocken, Pennsylvania by February 29, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $6,016.48 contract is for the supply of HUMIRA (CF) PEN 40 MG/0.4 MLS, a biologic medication used to treat various autoimmune conditions. AmerisourceBergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This contract serves as the...